TrialBlood advances2022

Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells.

J A C van Bruggen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.